Skip to content
About EUnetHTA 21
History of EUnetHTA
JA 3 Archive (2016-2021)
Early Dialogues
Early Dialogues for Pharmaceuticals
Early Dialogues for Medical Devices
Parallel Consultations
POP Database
EVIDENT Database
Events
2021 EUnetHTA Forum
2020 EUnetHTA Forum
2019 EUnetHTA Forum
2018 EUnetHTA Forum
2017 EUnetHTA Forum
EUnetHTA and the HTA Network
Organisation
The Executive Board
EUnetHTA Network
JA 2 Archive (2012-2015)
JA 1 Archive (2010-2012)
EUnetHTA Collaboration (2009)
EUnetHTA Project (2006-2008)
EUnetHTA Magazine
Acronyms
Vision, Mission, and Values
The Secretariat
Consortium Executive Board (CEB)
Committee for Scientific Quality & Consistency (CSCQ)
Conflict of Interest Committee (COIC)
Future Model of Cooperation (FMC) – White Paper
Joint HTA Work
Joint Clinical Assessments (JCA)
Assessment Archive (2006-2021)
Joint Scientific Consultations (JSC)
Parallel Consultation
PLEG
COVID-19 Response
Diagnostics
Treatments
Useful Links
Tools
HTA Core Model®
Methodology
EUnetHTA Companion Guide
REQueST® Tool
Partial use of GRADE and common phrases
PICO FAQ
Templates for Pharma and Med. Devices
Get Involved
Public Consultation
Events
Online Questionnaires
Menu
About EUnetHTA 21
History of EUnetHTA
JA 3 Archive (2016-2021)
Early Dialogues
Early Dialogues for Pharmaceuticals
Early Dialogues for Medical Devices
Parallel Consultations
POP Database
EVIDENT Database
Events
2021 EUnetHTA Forum
2020 EUnetHTA Forum
2019 EUnetHTA Forum
2018 EUnetHTA Forum
2017 EUnetHTA Forum
EUnetHTA and the HTA Network
Organisation
The Executive Board
EUnetHTA Network
JA 2 Archive (2012-2015)
JA 1 Archive (2010-2012)
EUnetHTA Collaboration (2009)
EUnetHTA Project (2006-2008)
EUnetHTA Magazine
Acronyms
Vision, Mission, and Values
The Secretariat
Consortium Executive Board (CEB)
Committee for Scientific Quality & Consistency (CSCQ)
Conflict of Interest Committee (COIC)
Future Model of Cooperation (FMC) – White Paper
Joint HTA Work
Joint Clinical Assessments (JCA)
Assessment Archive (2006-2021)
Joint Scientific Consultations (JSC)
Parallel Consultation
PLEG
COVID-19 Response
Diagnostics
Treatments
Useful Links
Tools
HTA Core Model®
Methodology
EUnetHTA Companion Guide
REQueST® Tool
Partial use of GRADE and common phrases
PICO FAQ
Templates for Pharma and Med. Devices
Get Involved
Public Consultation
Events
Online Questionnaires
Linkedin
Twitter
Envelope
Results
News
Home
/
Outputs
/
JA2-WP1
/
EUnetHTA JA2 Final Technical Report approved to be submitted to the European Commission
EUnetHTA JA2 Final Technical Report approved to be submitted to the European Commission
January 18, 2016
EUnetHTAJA2_FinalTechnicalReport_Executive Summary_May2016
More news
This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our
Privacy Policy
and our
Terms of Use
.
Accept and Close